Abstract Body

HIV post-treatment controllers (PTCs) are people with HIV who are able to maintain viral suppression after analytical treatment interruption (ATI). The dynamics of HIV-1 intact proviral reservoir size before and during ATI, however, remains underexplored. In this study, we evaluated HIV-1 proviral dynamics before and during ATI in PTCs and non-controllers (NCs).

The Control of HIV After Antiretroviral Medication Pause (CHAMP) study collected multiple treatment interruption trials from the AIDS Clinical Trials Group (ACTG) and the OPTIONS study. Only participants with reliably suppressed pre-ATI viral load were enrolled in those studies. PTCs were defined as those remaining off antiretroviral therapy (ART) for ?24 weeks with post-ATI viral loads ?400 copies/mL for at least 2/3 of the time points. We used intact proviral DNA assay (IPDA) to assess intact, defective, and total provirus before the ATI and at early and late time points during ATI. Near full length sequencing (NFL-seq) was performed on a subset of participants. We used the Wilcoxon test to assess differences between PTCs and NCs at each time point, with Benjamini-Hochberg correction for P values.

14 PTCs and 24 NCs were analyzed. Prior to ATI, PTCs had lower levels of intact (PTCs vs NCs, median 3.5 vs 14.7 intact copies/million PBMC, P=0.13) and defective provirus (median 19.8 vs 98.4 defective copies/million PBMC, P=0.01). During ATI, intact and defective proviral DNA levels remained largely stable in the PTCs, while NCs demonstrated significant increases in the intact reservoir over time (Figure). The timing of ART initiation did not have a significant impact on ATI proviral dynamics. During early ATI, NCs also demonstrated increased proinflammatory cytokines that were significantly associated with levels of total and intact proviral DNA. A subset of participants had NFL-seq results (n=8), with a median of 57 sequences per participant. The correlation between total proviral DNA as measured by the IPDA and NFL-seq was r=0.62, P=0.1, while no significant correlation between intact proviral DNA measured by IPDA and NFL-seq. Compared to NFL-seq, IPDA reported a median 40-fold higher levels of intact and 20-fold higher levels of total proviral DNA.

ATI virologic control in PTCs extends to significantly lower levels of intact and total HIV-1 provirus compared to NCs based on the IPDA assay. Additional studies are needed to explore the mechanisms behind the reservoir control by PTCs.